Emergency Medical Services Reimbursement for On-Scene and Support Act
Summary
HR7277 is an early-stage bill that would allow Medicare to reimburse ambulance services for on-scene treatment without transport. The bill has 8 cosponsors, no explicit funding authorization, and a long legislative path ahead. No direct near-term market impact on publicly traded companies is identifiable from this legislation alone.
See which stocks are affected
Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.
Already have an account? Log in
Key Takeaways
- 1.HR7277 is an early-stage bill with no funding authorization and a long path to enactment.
- 2.No publicly traded companies have a material direct exposure to this bill's provisions.
- 3.The bill's primary impact would be on municipal and regional ambulance service providers, not publicly traded firms.
Market Implications
No market implications in the near term. The bill is procedural and early-stage. Ambulance services in the US are dominated by non-profit and government entities, not large public corporations. Investors should monitor committee progress and any future markup that includes funding levels or scope expansion, but currently this bill has no identifiable impact on any traded security.
Full Analysis
Representative Balint introduced HR7277 on January 30, 2026, a bill that would amend the Social Security Act to expand Medicare coverage to include ambulance services where a provider or supplier treats a patient on-site without transporting them to a facility. The bill has been referred to the House Committee on Energy and Commerce and the Committee on Ways and Means—both standard initial steps. It currently has 8 cosponsors, all Democrats, indicating limited bipartisan momentum. A companion bill, S3730, exists in the Senate. The bill text includes no explicit funding authorization or appropriation; any future reimbursement rates would need to be set by the Centers for Medicare & Medicaid Services (CMS) rulemaking, and actual Medicare outlays would require separate appropriations. The legislative journey is in its earliest phase: committee hearings, markups, floor votes in both chambers, and potential conference remain. Given that ambulance services are predominantly provided by municipal fire departments, private non-profit services, and small regional operators rather than large publicly traded corporations, the direct market impact is minimal. No specific publicly traded company has a business model whose revenue would be materially affected by this change in the near term. The bill does not name or target any specific corporate entities.
Connected Signals
Matched on shared policy language across AI analyses, with ticker & timing weight
MERCK SHARP & DOHME LLC: $2.4B Department of Health and Human Services Contract Vehicle
PA DEPARTMENT OF HUMAN SERVICES: $1.0B Department of Health and Human Services Grant
STATE OF FLORIDA DIVISION OF EMERGENCY MANAGEMENT: $1.5B Department of Homeland Security Grant
HUMAN SERVICES, NEW JERSEY DEPARTMENT OF: $16.9B Department of Health and Human Services Grant
STATE OF FLORIDA DIVISION OF EMERGENCY MANAGEMENT: $2.9B Department of Homeland Security Grant
GOVERNOR'S AUTHORIZED REPRESENTATIVE: $1.8B Department of Homeland Security Grant
DEPARTMENT OF SOCIAL SERVICES MISSO: $15.1B Department of Health and Human Services Grant
MINNESOTA DEPARTMENT OF HUMAN SERVICES: $14.1B Department of Health and Human Services Grant
Related Presidential Actions
Executive orders & memoranda affecting the same sectors or companies
Regulatory Relief for Certain Stationary Sources to Promote American Chemical Manufacturing Security
President Trump issued a proclamation exempting certain chemical manufacturing facilities from compliance with the EPA's HON Rule for two years, citing unavailability of required technology and national security concerns. The exemption delays emissions-control deadlines and maintains pre-HON Rule standards for listed stationary sources, invoking authority under Clean Air Act section 112(i)(4).
Advancing Regenerative Agriculture and Strengthening American Farm Resilience
This executive order directs the EPA, USDA, and HHS to prioritize registration of alternative pesticides, expedite cumulative exposure research, and maximize funding for a regenerative agriculture pilot program, while creating public-private partnerships to expand adoption of conservation farming practices. The order specifically instructs the EPA Administrator to speed up registration actions for substances that can replace older active ingredients, and requires HHS to issue a grand prize challenge for cumulative chemical exposure evaluation technologies.
Implementing Schedule Policy/Career in the Excepted Service
This executive order expands the Schedule Policy/Career excepted service category, transferring certain federal positions from competitive service to at-will employment to facilitate removal for poor performance or misconduct. It directs agency heads to petition for reclassification of policy-influencing roles, mandates performance bonus pools for these employees, and amends civil service rules to exempt them from standard adverse action procedures.
Free — no credit card
Get the next market-moving signal before the news does
HillSignal scores every Congressional bill, federal contract, and insider filing for market impact and emails you the high-conviction ones — free, no credit card.
Weekly digest — the congressional activity that actually moved markets that week, in plain English. Free, one email.
Free forever plan · No credit card · Unsubscribe in one click
Want the live terminal too? Create a free account →